ANELLOVECTOR

Live / Registered — Registered (as of 06 Aug 2024)

What this means for you

Registered since 06 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98118232
Registration number
7469817
Mark type
Stylized text
Filed
04 Aug 2023
Published for opposition
02 Jan 2024
Registered
06 Aug 2024
Attorney of record
Christina M. Licursi

Goods and services

  • Class 005 — Pharmaceuticals: Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

Owner

Prosecution history

  • 06 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 06 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
  • 03 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 03 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 29 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 07 Mar 2024 — USE AMENDMENT FILED
  • 29 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 07 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
  • 27 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 02 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 02 Jan 2024 — PUBLISHED FOR OPPOSITION
  • 26 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 26 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 26 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 13 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View this trademark record on Marksy